Fortress Biotech
FBIO
54 hedge funds and large institutions have $23.4M invested in Fortress Biotech in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 5 closing their positions.
600% more call options, than puts
Call options by funds: $14K | Put options by funds: $2K
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
30% more capital invested
Capital invested by funds: $18M → $23.4M (+$5.41M)
10% more funds holding
Funds holding: 49 → 54 (+5)
0.04% more ownership
Funds ownership: 1.69% → 1.73% (+0.04%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2M |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$474K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$209K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$104K |
| 5 |
Corient Private Wealth
Miami,
Florida
|
+$97.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JFG
Jefferies Financial Group
New York
|
-$1.15M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$834K |
| 3 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
-$645K |
| 4 |
Millennium Management
New York
|
-$114K |
| 5 |
E
Ergoteles
New York
|
-$77.7K |
FBIO Hedge Fund Activity: Q1 2023 in Review
54 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q1 2023, worth a combined $23.4M — up 30% from $18M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new FBIO positions and 5 closed out — a net gain of 6 holders — while 16 added to existing stakes and 9 trimmed.
The largest buyer was Opaleye Management, adding an estimated $2M. The largest seller was Jefferies Financial Group, cutting an estimated $1.15M.
- 54 institutional investors held Fortress Biotech (FBIO) as of Q1 2023, up from 49 in Q4 2022.
- Funds reported $23.4M of Fortress Biotech stock for Q1 2023, up 30% quarter-over-quarter.
- 11 funds opened new Fortress Biotech positions in Q1 2023 and 5 closed out, a net change of +6 holders.
- The largest Fortress Biotech buyer in Q1 2023 was Opaleye Management, an estimated $2M added.
- The largest Fortress Biotech seller in Q1 2023 was Jefferies Financial Group, an estimated $1.15M sold.
Based on aggregated 13F filings for Q1 2023.